Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer
Abundant infiltration of tumor-associated macrophages (TAMs) within the tumor stroma plays a pivotal role in inducing immune escape in pancreatic cancer (PC). Lactate serves as a direct regulator of macrophage polarization and functions, although the precise regulation mechanism remains inadequately understood. Our study revealed that PC cells (PCs) promote macrophage polarization toward M2d through high lactate secretion. M2d is characterized by elevated secretion of IL-10 and VEGF-A, which diminish CD8<sup>+</sup>T cells cytotoxicity and promote tumor neoangiogenesis simultaneously. Additionally, we identify 2,5'-oligoadenylate synthase 3 (OAS3) as an essential regulator of M2d polarization, upregulated by PCs via lactate/METTL3/OAS3 axis. Increased OAS3 expression in TAMs correlates with m6A modification mediated by METTL3 on OAS3 mRNA and is associated with poorer prognosis in PC patients. OAS3 deficiency in macrophages substantially impairs IL-10<sup>high</sup>VEGF-A<sup>high</sup>M2d polarization and their pro-tumor functions while enhancing the therapeutic efficacy of gemcitabine and anti-PD-L1 mAb in humanized mouse models. In conclusion, OAS3 presents as a promising immune therapeutic target for reversing IL-10<sup>high</sup>VEGF-A<sup>high</sup>M2d infiltration and restoring CD8<sup>+</sup>T cell-mediated anti-tumor immunity in pancreatic cancer.
Authors
- Yitian Xu (ORCID: https://orcid.org/0000-0001-7577-4420)
- Kundong Zhang
- Haitao Gu (ORCID: https://orcid.org/0000-0003-1694-333X)
- Ximo Xu
- Chen Huang (ORCID: https://orcid.org/0000-0001-8535-6417)
- Pengshan Zhang
- Changzheng Lei
- Yuan Zhang (ORCID: https://orcid.org/0000-0002-1624-3715)
- Shaopeng Zhang (ORCID: https://orcid.org/0000-0002-9742-6221)
- Zhengjun Qiu (ORCID: https://orcid.org/0000-0002-8318-847X)
Institutions
- Shanghai Jiao Tong University (CN)
- Jiuquan Iron & Steel (China) (CN)
- Shanghai First People's Hospital (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1007/s00262-024-03898-w
- Citations
- 8
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.26
Funders
- National Natural Science Foundation of China